SeaStar Financial Statements From 2010 to 2026

ICU Stock  USD 2.40  0.09  3.90%   
Analyzing historical trends in various income statement and balance sheet accounts from SeaStar Medical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting SeaStar Medical's valuation are summarized below:
Gross Profit
840 K
Market Capitalization
9.1 M
Enterprise Value Revenue
4.7526
Revenue
881 K
Earnings Share
(11.30)
There are currently one hundred nine fundamental trend indicators for SeaStar Medical Holding that can be evaluated and compared over time across competition. All traders should double-check SeaStar Medical's current fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

SeaStar Medical Total Revenue

163,013

Check SeaStar Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SeaStar Medical's main balance sheet or income statement drivers, such as Tax Provision of 1.9 K, Depreciation And Amortization of 21.5 M or Interest Expense of 208.6 K, as well as many indicators such as Price To Sales Ratio of 43.04, Dividend Yield of 0.0 or Days Sales Outstanding of 242. SeaStar financial statements analysis is a perfect complement when working with SeaStar Medical Valuation or Volatility modules.
  
Build AI portfolio with SeaStar Stock
Check out the analysis of SeaStar Medical Correlation against competitors.

SeaStar Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 M5.4 M3.1 M
Slightly volatile
Short and Long Term Debt Total627.1 K660.1 K1.4 M
Slightly volatile
Other Current Liabilities4.7 M3.7 M2.2 M
Slightly volatile
Total Current Liabilities8.9 M7.9 MM
Slightly volatile
Accounts Payable2.2 M3.5 M1.1 M
Slightly volatile
Cash857.4 K1.6 M2.1 M
Slightly volatile
Non Current Assets Total796.4 KM321.3 K
Slightly volatile
Non Currrent Assets Other796.4 KM321.3 K
Slightly volatile
Other Assets1.6 K1.8 KK
Slightly volatile
Long Term Debt3.4 MM1.5 M
Slightly volatile
Cash And Short Term Investments857.4 K1.6 M2.1 M
Slightly volatile
Common Stock Shares Outstanding452.1 K430.6 K118.9 K
Slightly volatile
Liabilities And Stockholders Equity3.2 M5.4 M3.1 M
Slightly volatile
Non Current Liabilities Total3.7 M3.9 M48.9 M
Slightly volatile
Other Current Assets1.2 M2.1 M546.5 K
Slightly volatile
Other Stockholder Equity83.5 M158 M36.6 M
Slightly volatile
Total Liabilities5.8 M6.2 M51.9 M
Slightly volatile
Short and Long Term Debt627.1 K660.1 K610.7 K
Slightly volatile
Total Current Assets2.4 M4.3 M2.8 M
Very volatile
Short Term Debt627.1 K660.1 K610.7 K
Slightly volatile
Common StockK2.3 K923
Slightly volatile
Other Liabilities44 K49.5 K54 K
Slightly volatile

SeaStar Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization21.5 M20.5 M8.8 M
Slightly volatile
Interest Expense208.6 K219.6 K2.3 M
Slightly volatile
Selling General Administrative6.1 M10.2 MM
Slightly volatile
Selling And Marketing Expenses34.4 K28.8 K53.3 K
Slightly volatile
Other Operating Expenses12 M20.7 M8.9 M
Slightly volatile
Research Development5.4 M10.5 M4.8 M
Slightly volatile
Total Operating Expenses12 M20.7 M8.9 M
Slightly volatile

SeaStar Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation911.2 KM357.3 K
Slightly volatile
Begin Period Cash Flow150.5 K158.4 K2.3 M
Slightly volatile
Total Cash From Financing Activities21.3 M20.3 M7.9 M
Slightly volatile
End Period Cash Flow857.4 K1.6 M2.1 M
Slightly volatile
Other Cashflows From Investing Activities84.5 M95 M103.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio43.0448.4252.8529
Slightly volatile
Days Sales Outstanding242273297
Slightly volatile
Stock Based Compensation To Revenue5.265.916.4544
Slightly volatile
EV To Sales35.6640.1243.7933
Slightly volatile
Sales General And Administrative To Revenue52.5859.1564.5593
Slightly volatile
Research And Ddevelopement To Revenue53.9560.766.2539
Slightly volatile
Cash Per Share5.315.5936.4935
Slightly volatile
Income Quality0.990.741.3664
Slightly volatile
ROE10.7510.242.1752
Slightly volatile
Current Ratio0.810.631.886
Slightly volatile
Receivables Turnover0.971.081.1841
Slightly volatile
Revenue Per Share0.290.320.354
Slightly volatile
Interest Debt Per Share2.392.5163.246
Pretty Stable
Debt To Assets0.130.140.6204
Slightly volatile
Operating Cycle242273297
Slightly volatile
Ebt Per Ebit0.941.250.7694
Slightly volatile
Quick Ratio0.80.631.8525
Slightly volatile
Net Income Per E B T1.11.151.0165
Slightly volatile
Cash Ratio0.290.311.7433
Slightly volatile
Cash Conversion Cycle242273297
Slightly volatile
Days Of Sales Outstanding242273297
Slightly volatile
Debt Ratio0.130.140.6204
Slightly volatile
Price Sales Ratio43.0448.4252.8529
Slightly volatile
Asset Turnover0.02320.02610.0285
Slightly volatile
Return On Equity10.7510.242.1752
Slightly volatile

SeaStar Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.3 M8.4 M9.4 M
Slightly volatile
Enterprise Value13.5 M6.9 M16.8 M
Slightly volatile

SeaStar Fundamental Market Drivers

SeaStar Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About SeaStar Medical Financial Statements

SeaStar Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although SeaStar Medical investors may analyze each financial statement separately, they are all interrelated. The changes in SeaStar Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on SeaStar Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-4.5 M-4.3 M
Total Revenue155.2 K163 K
Stock Based Compensation To Revenue 5.91  5.26 
Sales General And Administrative To Revenue 59.15  52.58 
Research And Ddevelopement To Revenue 60.70  53.95 
Revenue Per Share 0.32  0.29 
Ebit Per Revenue(118.95)(124.89)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for SeaStar Stock Analysis

When running SeaStar Medical's price analysis, check to measure SeaStar Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SeaStar Medical is operating at the current time. Most of SeaStar Medical's value examination focuses on studying past and present price action to predict the probability of SeaStar Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SeaStar Medical's price. Additionally, you may evaluate how the addition of SeaStar Medical to your portfolios can decrease your overall portfolio volatility.